The Capsule Question: How Much Should Be Removed with Explantation of a Textured Device?

Plast Reconstr Surg. 2021 May 1;147(5S):44S-50S. doi: 10.1097/PRS.0000000000008045.

Abstract

Current controversies surrounding breast implants are focused not only on the implant but also on the capsule. There has been tremendous discussion regarding how much of the capsule, if any, should be removed during explantation for benign conditions. The appearance of benign capsules is highly variable ranging from a thin membrane to densely fibrotic with calcifications. The options for capsulectomy include none, partial, complete, complete-intact, and en bloc. Some patients are requesting en bloc capsulectomy even in the absence of anaplastic large cell lymphoma; however, the scientific evidence only supports this for patients with capsular malignancies. The purpose of this article is to review the old and new evidence to answer the question regarding how much capsule should be removed during explantation for benign conditions.

MeSH terms

  • Breast Implantation
  • Breast Implants / adverse effects*
  • Breast Neoplasms / etiology
  • Breast Neoplasms / prevention & control
  • Breast Neoplasms / surgery
  • Collagen
  • Device Removal / methods*
  • Female
  • Fibrosis
  • Foreign-Body Migration
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / etiology
  • Lymphoma, Large-Cell, Anaplastic / prevention & control
  • Lymphoma, Large-Cell, Anaplastic / surgery
  • Margins of Excision
  • Metaplasia
  • Surface Properties
  • Synoviocytes / pathology

Substances

  • Collagen